Guru Ownership Trend
Guru Analysis for Acrivon Therapeutics, Inc. (ACRV)
Acrivon Therapeutics, Inc. (ACRV), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.34 M.
Top institutional holders include Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $752.94 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 0.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Acrivon Therapeutics, Inc. (ACRV)
Major holders include Renaissance Technologies (RenTech) ($1.35 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 758,863 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $752.94, with 1 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in ACRV during the most recent reporting period.
Yes, 0 managers opened new positions in ACRV, and 1 increased their existing holdings. The total reported buy value was $752.94.